REFERENCE MATERIALS FOR EASY ACCESS

REFERENCES Catching Up With Tara DeMond 1. http://thegratefulveteran.com/ The Grateful Veteran 2. https://ballotpedia.org/Florida_Medical_Marijuana_Legaliza- tion,_Amendment_2_(2016) Ballotpedia. 2016. “Florida Medical Marijuana Legalization.” http://ballotpedia.org CBD + Parkinson’s Disease 1. Zuardi, A.W., et al. Journal of Psychopharmacology 23, no. 8. 2009.doi:10.1177/0269881108096519. 2. Chagas, M.H.N., et al. Journal of Clinical Pharmacy and Therapeutics, 39. 2014. doi: 10.1111/jcpt.12179 3. Chagas, M.H.N., et al. Journal of Psychopharmacology, 28, no. 11. 2014. doi: 10.1177/0269881114550355 4. Santos, N.A.G., et al. Toxicology in Vitro, 30(1B). 2015. doi: 10.1016/j.tiv.2015.11.004 5. Iuvone, T., et al. CNS Neuroscience & Therapeutics, 15: 65- 75. 2009. doi: 10.1111/j/1755-5949.2008.00065.x 6. Consroe P., et al. International Journal of Neuroscience, 30:4. 1986. doi: 10.3109/00207458608985678 7. Fernández‐Ruiz, J., et al. British Journal of Clinical Pharmacology, 75: 323-333. 2013. doi: 10.1111/j.1365- 2125.2012.04341.x 8. Peres Fernanda F., et al. Frontiers in Pharmacology, 28 Sep- tember 2016. doi: 10.3389/fphar.2016.00343 9. Devore, C. Fatal Employment: Men 10 Times More Likely Than Women To Be Killed At Work. Forbes. www.forbes.com 10.“Symptoms of Parkinson’s.” American Parkinson Disease Association. www. apdaparkinson.org 11. Lastres-Becker, I., et al. (Abstract) Neurobiology of disease, 19(1-2), 96–107. 2005. Plant Medicine 1. Chan, C.S., et al. Frontiers in Aging Neuroscience, 10:349. 2018. doi: 10.3389/fnagi.2018.00349 2. Kim, T.H., et al. PLoS One, 7(5): e35695. 2012. doi: 10.1371/ journal.pone.0035695 3. Wei, R.R., et al. Evidence-Based Complementary and Alter- native Medicine. 2018. doi: 10.1155/2018/6142065 4. Gourie-Devi, M. et al. Journal of the Royal Society of Medi- cine, 84(8): 491-491. 1991. 5. Cilia, R. et al. Neurology, 89(5). 2017. doi: 10.1212/ WNL.0000000000004175 6. Amro, M.S., et al. La Clinica Terapeutica, 169(1). 2018. doi: 10.7417/T.2018.2050. 7. Filograna, R. et al. Current Neuropharmacology, 14(3). 2016. doi: 10.2174/1570159X13666151030102718 8. Tanaka, K. et al. Current Neuropharmacology, 11(4). 2013. doi: 10.2174/1570159X11311040006 Medical Minute 1. Mohanty, D. & Lippmann, S. Innovations in Clinical Neurosci- ence, 16 (1-2). 2019. 2. Mayo Clinic. Parkinson’s Disease. www.mayoclinic.org 3. NORML. Medical Marijuana. Information for each state. norml.org 4. Chagas, M.H.N., et al. Journal of Psychopharmacology Sep. 18, 2014. doi: 10.1177/0269881114550355 5. Kluger, B. et al. Movement Disorder, 30(3). 2015. doi: 10.1002/mds.26142 6. Lotan, I. et al. Clinical Neuropharmacology, 37(2). 2014. doi: 10.1097/WNF.0000000000000016 7. Medical Marijuana and Parkinson’s Part 3 of 3. November 21, 2016. Ride with Larry. www.youtube.com Dr. Ethan Russo 1. McPhee, J. “A Forager.” The New Yorker. March 30, 1968 2. Russo, E. Pain Medicine, 20(11). 2019. doi: 10.1093/pm/ pnz227 disList - ALS 1. ALS Association. “What is ALS?” www.als.org 2. The Lancet.. ScienceDaily, 13 December 2018. https://www. sciencedaily.com/releases/2018/12/181213190606.htm 3. Riva, N. et al. Lancet Neurology, 2018. doi: 10.1016/S1474- 4422(18)30406-X 4. Weber M., et al. Journal of Neurology, Neurosurgery & Psy- chiatry, 81. 2010. doi: 10.1136/jnnp.2009.200642 5. Carter, G.T., & Rosen, B.S. American Journal of Hos- pice and Palliative Medicine, 18, no. 4. July 2001. doi: 10.1177/104990910101800411 6. Raman, C. et al. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5:1. 2004. doi: 10.1080/14660820310016813 7. Giacoppo, S., & Mazzon, E. Neural regeneration research, 11(12). 2016. doi: 10.4103/1673-5374.197125 8. Shoemaker, J.L., et al. Journal of Neurochemistry, 101. 2007. doi: 10.1111/j.1471-4159.2006.04346.x 9. Pryce G., & Baker D. Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis. In: Pertwee R. (eds) Endo- cannabinoids. Handbook of Experimental Pharmacology, vol 231. 2015.

50 dis-List Melanoma 1. Bertoni, J.M. et al. JAMA Neurology. 2010. doi:10.1001/arch- neurol.2010.1 2. Huang, P. et al. Translational Neurodegeneration, 4 (21). 2015. doi: 10.1186/s40035-015-0044-y 3.Skin Cancer Foundation. “Skin Cancer Facts and Statistics.” www.skincancer.org. 4. American Cancer Society. “What is Melanoma Skin Cancer?” www.cancer.org 5. Skin Cancer Foundation. “Can your diet help prevent skin cancer?” June 8, 2017. www.skincancer.org 6. Paur, I. et al. Herbal Medicine: Biomolecular and Clinical As- pects. 2nd edition. 2011. 7. Pertwee, R. Pharmacology and Therapeutics, Volume 74, Is- sue 2. 1997. doi: 10.1016/S0163-7258(97)82001-3 8. Blazquez, C. et al. Federation of American Societies for Ex- perimental Biologies. 2006. doi: 10.1096/fj.06-6638fje 9. Simmerman, E. et al. Journal of Surgical Research, Volume 235. March 2019. doi: 10.1016/j.jss.2018.08.055 10. Safaraz, S. et al. American Association for Cancer Research. January 2008. doi: 10.1158/0008-5472.CAN-07-2785 11. “Mayo Clinic Minute: The A, B, C, D, E’s of Skin Cancer.” Ian Roth. May 1, 2018. mayoclinic.org. dis-List Tremors 1 De Faria, S.M, et al. Journal of Pyschopharmacology, 7:269881119895536. 2020 doi: 10.1177/0269881119895536. 2 Venderova K, et al. Movement Disorders, 19(9):1102–1106. 2004. 3 Lotan, I. et al. Clinical Neuropharmacology, 37(2). 2014. doi: 10.1097/WNF.0000000000000016. 4 Baker D, et al. Nature, 404(6773):84–87. 2000. 5 Abbassian, H. et al. British Journal of Pharmacology, 173(22). 2016. doi: 10.1111/bph.13581. 6 Zajicek J., et al. Lancet, 362(9395):1517–1526. 2003. 7 Collin C., et al. Neurological Research, 32(5):451–459. 2010. 8 International Essential Tremor Foundation https://www. essentialtremor.org/ disLIST - Weight Loss 1. Alshaarawy, O., & Anthony, J. International Journal of Epide- miology, 48(5) 2019. doi: 10.1093/ije/dyz044 2. Penner, E. A., et al. The American Journal of Medicine, 126(7). 2013. doi: 10.1016/j.amjmed.2013.03.002 3. Thomas, A. et al. Lesley A Stevenson, Kerrie N Wease, Mar- tin R Price, Gemma Baillie, Ruth A Ross, and Roger G Pertwee. British Journal of Pharmacology, 146(7). 2005. doi: 10.1038/ sj.bjp.0706414 4. Pradhan, G. et al. Current Opinion in Clinical Nu- trition and Metabolic Care, 16(6). 2013. doi: 10.1097/ MCO.0b013e328365b9be 5. Parker, L.A., et al. British Journal of Pharmacology, 163(7) 2011. doi: 10.1111/j.1476-5381.2010.01176.x 6. “Adult Obesity Facts.” Centers for Disease Control and Pre- vention. www.cdc.gov Cannabis, Parkinson’s + The Great Outdoors 1. Nieuwboer A., et al. Journal of Neurology, Neurosurgery & Psychiatry 2007;78:134-140. 2. Dontje M. L., et al. Parkinsonism & Related Disorders. 2013 Oct;19(10):878-82. doi: 10.1016/j.parkreldis.2013.05.014. 3. Miller, I. N., & Cronin-Golomb, A. Movement disorders: official journal of the Movement Disorder Society. 2010; 25(16), 2695–2703. 4. Portegijs, E. et al. Journal of the American Geriatrics Soci- ety. 2014; 62: 615– 621. 5. Devore, Chuck. https://www.forbes.com/sites/chuckde- vore/2018/12/19/fatal-employment-men-10-times-more-likelythan-women-to-be-killed-at-work/#5fecf0df52e8 6. Kenborg, L., et al. Occupational and environmental medi- cine.2011; 68(4), 273–278. 7. Danique L.M. et al. International Journal of Neuroscience, 2017; 127:10, 930-943, doi: 10.1080/00207454.2016.1275617. 8. Ottosson, J.,et al. International journal of environmental research and public health. 2015; 12(7), 7274–7299. 9. Bloem, B. R., Munneke, M. Michael J Fox Foundation for Parkinson’s Research. 2011. 10. van Nimwegen M., et al. BMC Neurology. 2010;10:70. 11. Speelman, A. D., et al. Physiotherapy. 2014; 100(2), 134–141. 12. Kolk, N. et al. Parkinsonism & Related Disorders. 2014; 20. doi:10.1016/j.parkreldis.2014.10.004.

NATURAL PLANT MEDICINES NEXT UP...